Navigation Links
New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
Date:9/24/2011

groups of the disease and demographic variables such as age, ethnicity, and geographical location. From this we can conclude that, whatever the patient characteristics (initially based on a high prostate specific antigen (PSA) value [3] and/or a short PSA doubling time), denosumab can delay the appearance of bone metastasis. In a condition where there is currently no effective treatment, this is a highly significant finding," Prof Oudard will say.

According to the researchers, patients with bone metastases have an almost five times higher risk of death compared with patients without bone metastases. "Effective therapies are already in place for both early (hormone-sensitive) and advanced (hormone-resistant) prostate cancer, but until now there was a gap in the treatment plan for this group of patients, who are hormone-resistant but have not yet developed metastatic disease," says Prof Oudard.

The trial showed that the adverse effects of the drug were limited, being relatively similar between both the denosumab and the placebo groups. Low blood calcium levels and osteonecrosis of the jaw, a deterioration of the jawbone, were slightly more frequent in the denosumab group, and back pain was the most commonly reported adverse effect in this group.

"Bone is one of the most common places for cancer to spread, and we believe that it is a very fertile environment for tumour cells," says Prof Oudard. "When cancer spreads to bone, the tumour cells settle in their new micro-environment and continue to grow. Once established, they increase the breakdown of bone, which releases an excess of growth factors back into the blood stream, which then further stimulate tumour growth."

Patients with bone metastases face critical complications. Often the first symptom is pain, which can be severe and debilitating in the majority of patients. Growth of the tumour in the bone weakens the bone itself and puts the patients at risk for serious skeletal-relat
'/>"/>

Contact: Mary Rice
mary.rice@riceconseil.eu
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Phase II study shows new cancer drug combination significantly delays breast cancer progression
2. Emergency treatment for heart attack improving but delays still occur
3. ADHD Drug Delays Puberty in Male Monkeys, Study Finds
4. One-Third of Severe Heart Attack Patients Have Treatment Delays
5. Many Pediatricians Arent Testing Tots for Developmental Delays
6. Hospital Delays Tied to Racial Divide in Heart Attack Care
7. Delays in Hospital Transfers for Heart Attack Patients May Raise Death Risk
8. Language Delays Seen in Kids in Institutions Beyond Age 2
9. Antifungal drug delays need for chemo in advanced prostate cancer
10. FDA Panel Delays Action on Dyes Used in Foods
11. Outcomes improved by longer delays between heart attacks and elective surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 The term nutraceuticals ... Pharameuticals. Nutraceuticals is a source of healthy-dietary supplements ... natural food sources. Nutraceutical ingredients have certain curative ... human body. Nutraceutical health products include factors such ... and more. Although nature is the most bountiful ...
(Date:8/30/2014)... Acne is a common problem millions of American ... more than a daily nuisance, for some, it can have a ... can even lead to dramatic mood swings and depression. , ... clear up their skin. In some cases, that can make the ... and error, those on a quest for clearer skin can now ...
(Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
(Date:8/30/2014)... commonly used to treat gout, before and after ... complications from this type of surgery, but it ... according to a study published by JAMA ... to coincide with its presentation at the European ... cardiac surgery include postpericardiotomy syndrome (the occurrence of ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) ... company’s request to sever four cases selected for ... an Order issued on August 18, 2014, U.S. ... District of West Virginia disagrees with Boston Scientific’s ...
Breaking Medicine News(10 mins):Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3
... , , PHILADELPHIA, July 22 ... on the role of cell receptors in acting as gatekeepers for ... receptor in heart and pancreas cells, the study team prevented infection ... , , "This finding is a ...
... , New organization aims to ... to improve patient care , , ... and Medfinders, Inc., have formed a joint venture designed to help ... nurses and allied healthcare professionals. Medfinders, the parent company of ...
... ... of Sleep Medicine Certification. The Atlanta School of Sleep Medicine and Technology will offer a ... that is essential for success on the exam. , ... Atlanta, GA (PRWEB) July 22, 2009 -- Physicians interested in becoming ...
... , , NEW ... age, coupled with billions of dollars in economic stimulus funding, life ... of maximizing the value of data and automation efficiencies. That,s one ... Study for Life Sciences and Health Care companies. Worse yet, inadequate ...
... DALLAS, July 22 The American Heart Association,s Get With ... participating hospitals entered the one millionth stroke patient record into ... "The American Heart Association and American Stroke Association are delighted ... The Guidelines-Stroke," said Lee Schwamm, M.D., volunteer chairman of the ...
... , WASHINGTON, July 22 The role of personal ... book, Rethinking Responsibility: Reflections on Sex and Accountability. ... Pregnancy, a nonprofit, nonpartisan organization, the volume includes 29 essays written ... , , Leading ...
Cached Medicine News:Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 2Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 3Health News:Texas Health Resources and Medfinders, Inc. Form Joint Venture to Recruit and Manage Contract Medical Professionals 2Health News:Texas Health Resources and Medfinders, Inc. Form Joint Venture to Recruit and Manage Contract Medical Professionals 3Health News:Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 2Health News:Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 3Health News:Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 4Health News:Life Sciences & Health Care Companies Unprepared for Information Security Risks: Deloitte Survey 2Health News:Life Sciences & Health Care Companies Unprepared for Information Security Risks: Deloitte Survey 3Health News:Life Sciences & Health Care Companies Unprepared for Information Security Risks: Deloitte Survey 4Health News:National Stroke Quality Improvement Program Passes the Million Mark 2Health News:National Leaders Examine Sex and Responsibility in New Book 2Health News:National Leaders Examine Sex and Responsibility in New Book 3
(Date:8/29/2014)... 29, 2014 Diseases largely eradicated in ... are returning. Measles was declared eliminated in 2000, yet ... of August 15—the highest incidence in 20 years. In ... declared whooping cough a problem of "epidemic proportions." ... and dying from these preventable diseases—in part because some ...
(Date:8/29/2014)... 2014  In part four of a ... pharmacy as a strategic asset, Mary Baxter, MBA, ... Cardinal Health,s Innovation Delivery Solutions business, discusses how expanding ... hospitals and patients. "Every hospital pharmacist knows ... their job in a value-based healthcare world," Baxter says. ...
(Date:8/29/2014)... Pixcelldata, the innovative Irish developer ... a major new deal with Dutch based eX-Path, global ... Dr. Marius Nap . The announcement ... of Pathology which is taking placing between August 30th ... London where Pixcelldata will demonstrate its innovative ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... Mass., Jan. 31, 2011 Hologic, Inc. (Hologic or the ... and supplier of premium diagnostics products, medical imaging systems and ... today announced its results for the first fiscal quarter ended ... quarter include: Revenues of $432.6 million. Net income ...
... 2011 ImaginAb, Inc. and Eurogentec S.A. announce ... for producing engineered antibody fragments. The two companies ... high-performance Pichia pastoris expression system. Leveraging ... the collaboration will accelerate the development of ImaginAb,s ...
Cached Medicine Technology:Hologic Announces First Quarter Fiscal 2011 Operating Results 2Hologic Announces First Quarter Fiscal 2011 Operating Results 3Hologic Announces First Quarter Fiscal 2011 Operating Results 4Hologic Announces First Quarter Fiscal 2011 Operating Results 5Hologic Announces First Quarter Fiscal 2011 Operating Results 6Hologic Announces First Quarter Fiscal 2011 Operating Results 7Hologic Announces First Quarter Fiscal 2011 Operating Results 8Hologic Announces First Quarter Fiscal 2011 Operating Results 9Hologic Announces First Quarter Fiscal 2011 Operating Results 10Hologic Announces First Quarter Fiscal 2011 Operating Results 11Hologic Announces First Quarter Fiscal 2011 Operating Results 12Hologic Announces First Quarter Fiscal 2011 Operating Results 13Hologic Announces First Quarter Fiscal 2011 Operating Results 14Hologic Announces First Quarter Fiscal 2011 Operating Results 15ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia 2
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Endotracheal Tube - Soft red rubber. Silkolatex™ coated. Silkolatex™ cuff. Magill tip - oral. Graduated. X-ray opaque....
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St...
Medicine Products: